Losers: DatChat DATS -32% plans to sell shares through public offering. Acurx Pharmaceuticals (NASDAQ:ACXP) -24% announces positive comparative Microbiology and Microbiome data for Ibezapolstat from ...
Source LinkLosers: DatChat DATS -32% plans to sell shares through public offering. Acurx Pharmaceuticals (NASDAQ:ACXP) -24% announces positive comparative Microbiology and Microbiome data for Ibezapolstat from ...
Source Link
Comments